STOCK TITAN

[Form 4] Ventas, Inc. Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Ventas, Inc. (VTR) Form 4: EVP & CFO Robert F. Probst exercised 3,900 stock options at an exercise price of $65.45 on 07/31/2025 and simultaneously sold the same 3,900 common shares at a weighted-average price of $68.4513. The transactions were executed under a Rule 10b5-1 trading plan adopted on 02/19/2025 and relate to fully-vested options that would have expired on 05/04/2026.

Following the sale, Probst’s direct ownership stands at 168,364 shares of common stock and 63,282 unexercised options. The disposal represents roughly 2.3 % of his post-transaction share holdings, suggesting a modest liquidity event rather than a substantial reduction in exposure.

No company fundamentals, earnings data, or new strategic information were disclosed; the filing strictly details insider trading activity. Given the limited size of the sale and the officer’s continued large stake, the market impact is expected to be minimal.

Ventas, Inc. (VTR) Modulo 4: Il EVP e CFO Robert F. Probst ha esercitato 3.900 opzioni azionarie al prezzo di esercizio di $65,45 il 31/07/2025 e ha venduto simultaneamente le stesse 3.900 azioni ordinarie ad un prezzo medio ponderato di $68,4513. Le operazioni sono state effettuate nell’ambito di un piano di trading Rule 10b5-1 adottato il 19/02/2025 e riguardano opzioni completamente maturate che sarebbero scadute il 04/05/2026.

Dopo la vendita, la proprietà diretta di Probst ammonta a 168.364 azioni ordinarie e 63.282 opzioni non esercitate. La cessione rappresenta circa il 2,3% delle sue partecipazioni azionarie post-transazione, indicando un evento di liquidità moderato piuttosto che una significativa riduzione dell’esposizione.

Non sono stati divulgati dati fondamentali dell’azienda, risultati economici o nuove informazioni strategiche; il documento dettaglia esclusivamente l’attività di trading degli insider. Considerando la limitata entità della vendita e la consistente partecipazione dell’amministratore, l’impatto sul mercato dovrebbe essere minimo.

Ventas, Inc. (VTR) Formulario 4: El EVP y CFO Robert F. Probst ejerció 3,900 opciones sobre acciones a un precio de ejercicio de $65.45 el 31/07/2025 y vendió simultáneamente las mismas 3,900 acciones ordinarias a un precio promedio ponderado de $68.4513. Las transacciones se realizaron bajo un plan de negociación Rule 10b5-1 adoptado el 19/02/2025 y corresponden a opciones totalmente adquiridas que habrían expirado el 04/05/2026.

Tras la venta, la propiedad directa de Probst es de 168,364 acciones ordinarias y 63,282 opciones no ejercidas. La disposición representa aproximadamente el 2.3% de sus participaciones accionarias posteriores a la transacción, sugiriendo un evento de liquidez moderado más que una reducción significativa de su exposición.

No se divulgaron fundamentos de la empresa, datos de ganancias ni nueva información estratégica; el informe detalla estrictamente la actividad de negociación de los insiders. Dado el tamaño limitado de la venta y la continua gran participación del ejecutivo, se espera que el impacto en el mercado sea mínimo.

Ventas, Inc. (VTR) Form 4: EVP 겸 CFO인 Robert F. Probst가 2025년 7월 31일에 3,900 주식 옵션을 행사했으며, 행사 가격은 $65.45였습니다. 동시에 동일한 3,900 보통주를 가중평균 가격 $68.4513에 매도했습니다. 이 거래는 2025년 2월 19일에 채택된 Rule 10b5-1 거래 계획에 따라 이루어졌으며, 2026년 5월 4일에 만료될 예정이었던 완전 취득 옵션과 관련이 있습니다.

매도 후 Probst의 직접 보유 주식은 168,364 주의 보통주와 63,282 개의 미행사 옵션입니다. 이번 처분은 거래 후 보유 주식의 약 2.3%에 해당하며, 이는 노출을 크게 줄이기보다는 소규모 유동성 확보 이벤트임을 시사합니다.

회사 기본 정보, 실적 데이터 또는 새로운 전략 정보는 공개되지 않았으며, 제출 서류는 내부자 거래 활동만을 상세히 기록하고 있습니다. 매도 규모가 제한적이고 임원의 지분이 계속 큰 점을 고려할 때 시장에 미치는 영향은 미미할 것으로 예상됩니다.

Ventas, Inc. (VTR) Formulaire 4 : Le EVP et CFO Robert F. Probst a exercé 3 900 options d'achat d'actions au prix d'exercice de 65,45 $ le 31/07/2025, puis a simultanément vendu les mêmes 3 900 actions ordinaires à un prix moyen pondéré de 68,4513 $. Ces opérations ont été réalisées dans le cadre d'un plan de négociation Rule 10b5-1 adopté le 19/02/2025 et concernent des options entièrement acquises qui auraient expiré le 04/05/2026.

Après la vente, la détention directe de Probst s'élève à 168 364 actions ordinaires et 63 282 options non exercées. Cette cession représente environ 2,3 % de ses participations post-transaction, indiquant un événement de liquidité modéré plutôt qu'une réduction significative de son exposition.

Aucune donnée fondamentale, résultat financier ou nouvelle information stratégique n'a été divulguée ; le dépôt détaille strictement l'activité de trading des initiés. Étant donné la taille limitée de la vente et la participation importante continue de l'officier, l'impact sur le marché devrait être minimal.

Ventas, Inc. (VTR) Formular 4: EVP & CFO Robert F. Probst übte am 31.07.2025 3.900 Aktienoptionen zum Ausübungspreis von 65,45 $ aus und verkaufte gleichzeitig dieselben 3.900 Stammaktien zu einem gewichteten Durchschnittspreis von 68,4513 $. Die Transaktionen erfolgten im Rahmen eines Rule 10b5-1 Handelsplans, der am 19.02.2025 angenommen wurde, und beziehen sich auf vollständig erworbene Optionen, die am 04.05.2026 verfallen wären.

Nach dem Verkauf hält Probst direkt 168.364 Stammaktien und 63.282 nicht ausgeübte Optionen. Die Veräußerung entspricht etwa 2,3 % seines Aktienbestands nach der Transaktion und deutet auf ein moderates Liquiditätsereignis hin, nicht auf eine wesentliche Reduzierung seiner Beteiligung.

Es wurden keine Unternehmenskennzahlen, Gewinnzahlen oder neue strategische Informationen veröffentlicht; die Meldung beschreibt ausschließlich Insider-Handelsaktivitäten. Aufgrund der begrenzten Verkaufsgröße und der weiterhin großen Beteiligung des leitenden Angestellten wird der Markteinfluss voraussichtlich gering sein.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine 3,900-share option exercise and sale by VTR CFO; small versus total holdings, limited valuation impact.

The transaction looks like standard housekeeping ahead of an option’s 2026 expiry. Probst monetised a $3/share spread, realising roughly $12k gross before taxes. The Rule 10b5-1 plan indicates pre-scheduled intent, reducing potential signalling risk. Remaining ownership—over 168k shares plus 63k options—maintains strong alignment with shareholders. Volumes are negligible compared with Ventas’s daily average (~2 m shares), so I view the filing as neutral for the stock.

Ventas, Inc. (VTR) Modulo 4: Il EVP e CFO Robert F. Probst ha esercitato 3.900 opzioni azionarie al prezzo di esercizio di $65,45 il 31/07/2025 e ha venduto simultaneamente le stesse 3.900 azioni ordinarie ad un prezzo medio ponderato di $68,4513. Le operazioni sono state effettuate nell’ambito di un piano di trading Rule 10b5-1 adottato il 19/02/2025 e riguardano opzioni completamente maturate che sarebbero scadute il 04/05/2026.

Dopo la vendita, la proprietà diretta di Probst ammonta a 168.364 azioni ordinarie e 63.282 opzioni non esercitate. La cessione rappresenta circa il 2,3% delle sue partecipazioni azionarie post-transazione, indicando un evento di liquidità moderato piuttosto che una significativa riduzione dell’esposizione.

Non sono stati divulgati dati fondamentali dell’azienda, risultati economici o nuove informazioni strategiche; il documento dettaglia esclusivamente l’attività di trading degli insider. Considerando la limitata entità della vendita e la consistente partecipazione dell’amministratore, l’impatto sul mercato dovrebbe essere minimo.

Ventas, Inc. (VTR) Formulario 4: El EVP y CFO Robert F. Probst ejerció 3,900 opciones sobre acciones a un precio de ejercicio de $65.45 el 31/07/2025 y vendió simultáneamente las mismas 3,900 acciones ordinarias a un precio promedio ponderado de $68.4513. Las transacciones se realizaron bajo un plan de negociación Rule 10b5-1 adoptado el 19/02/2025 y corresponden a opciones totalmente adquiridas que habrían expirado el 04/05/2026.

Tras la venta, la propiedad directa de Probst es de 168,364 acciones ordinarias y 63,282 opciones no ejercidas. La disposición representa aproximadamente el 2.3% de sus participaciones accionarias posteriores a la transacción, sugiriendo un evento de liquidez moderado más que una reducción significativa de su exposición.

No se divulgaron fundamentos de la empresa, datos de ganancias ni nueva información estratégica; el informe detalla estrictamente la actividad de negociación de los insiders. Dado el tamaño limitado de la venta y la continua gran participación del ejecutivo, se espera que el impacto en el mercado sea mínimo.

Ventas, Inc. (VTR) Form 4: EVP 겸 CFO인 Robert F. Probst가 2025년 7월 31일에 3,900 주식 옵션을 행사했으며, 행사 가격은 $65.45였습니다. 동시에 동일한 3,900 보통주를 가중평균 가격 $68.4513에 매도했습니다. 이 거래는 2025년 2월 19일에 채택된 Rule 10b5-1 거래 계획에 따라 이루어졌으며, 2026년 5월 4일에 만료될 예정이었던 완전 취득 옵션과 관련이 있습니다.

매도 후 Probst의 직접 보유 주식은 168,364 주의 보통주와 63,282 개의 미행사 옵션입니다. 이번 처분은 거래 후 보유 주식의 약 2.3%에 해당하며, 이는 노출을 크게 줄이기보다는 소규모 유동성 확보 이벤트임을 시사합니다.

회사 기본 정보, 실적 데이터 또는 새로운 전략 정보는 공개되지 않았으며, 제출 서류는 내부자 거래 활동만을 상세히 기록하고 있습니다. 매도 규모가 제한적이고 임원의 지분이 계속 큰 점을 고려할 때 시장에 미치는 영향은 미미할 것으로 예상됩니다.

Ventas, Inc. (VTR) Formulaire 4 : Le EVP et CFO Robert F. Probst a exercé 3 900 options d'achat d'actions au prix d'exercice de 65,45 $ le 31/07/2025, puis a simultanément vendu les mêmes 3 900 actions ordinaires à un prix moyen pondéré de 68,4513 $. Ces opérations ont été réalisées dans le cadre d'un plan de négociation Rule 10b5-1 adopté le 19/02/2025 et concernent des options entièrement acquises qui auraient expiré le 04/05/2026.

Après la vente, la détention directe de Probst s'élève à 168 364 actions ordinaires et 63 282 options non exercées. Cette cession représente environ 2,3 % de ses participations post-transaction, indiquant un événement de liquidité modéré plutôt qu'une réduction significative de son exposition.

Aucune donnée fondamentale, résultat financier ou nouvelle information stratégique n'a été divulguée ; le dépôt détaille strictement l'activité de trading des initiés. Étant donné la taille limitée de la vente et la participation importante continue de l'officier, l'impact sur le marché devrait être minimal.

Ventas, Inc. (VTR) Formular 4: EVP & CFO Robert F. Probst übte am 31.07.2025 3.900 Aktienoptionen zum Ausübungspreis von 65,45 $ aus und verkaufte gleichzeitig dieselben 3.900 Stammaktien zu einem gewichteten Durchschnittspreis von 68,4513 $. Die Transaktionen erfolgten im Rahmen eines Rule 10b5-1 Handelsplans, der am 19.02.2025 angenommen wurde, und beziehen sich auf vollständig erworbene Optionen, die am 04.05.2026 verfallen wären.

Nach dem Verkauf hält Probst direkt 168.364 Stammaktien und 63.282 nicht ausgeübte Optionen. Die Veräußerung entspricht etwa 2,3 % seines Aktienbestands nach der Transaktion und deutet auf ein moderates Liquiditätsereignis hin, nicht auf eine wesentliche Reduzierung seiner Beteiligung.

Es wurden keine Unternehmenskennzahlen, Gewinnzahlen oder neue strategische Informationen veröffentlicht; die Meldung beschreibt ausschließlich Insider-Handelsaktivitäten. Aufgrund der begrenzten Verkaufsgröße und der weiterhin großen Beteiligung des leitenden Angestellten wird der Markteinfluss voraussichtlich gering sein.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
CAFARO DEBRA A

(Last) (First) (Middle)
C/O VENTAS, INC.
300 NORTH LASALLE ST., SUITE 1600

(Street)
CHICAGO IL 60654

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Ventas, Inc. [ VTR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chairman and CEO
3. Date of Earliest Transaction (Month/Day/Year)
08/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/01/2025 M 10,322(1) A $65.45 1,156,017 D
Common Stock 08/01/2025 S 10,322(1) D $67.4019(2) 1,145,695 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) $65.45 08/01/2025 M 10,322 05/04/2016(3) 05/04/2026 Common Stock 10,322 $0 691,609(4) D
Explanation of Responses:
1. The transaction involved the exercise of fully vested options scheduled to expire in the next 10 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024.
2. The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $66.67 to $67.85, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. Fully vested.
4. Represents total number of unexercised options to purchase shares of Issuer's Common Stock held by the Reporting Person.
Remarks:
Debra A. Cafaro By: /s/ Kenneth Hagan, Attorney-In-Fact 08/01/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Ventas

NYSE:VTR

VTR Rankings

VTR Latest News

VTR Latest SEC Filings

VTR Stock Data

30.01B
451.86M
0.57%
99.91%
2.85%
REIT - Healthcare Facilities
Real Estate Investment Trusts
Link
United States
CHICAGO